Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

VEGF165 Rabbit pAb, IRDye 800CW conjugated

VEGF165 Rabbit pAb, IRDye 800CW conjugated is a IRDye800 conjugated antibody targeting VEGFA. This antibody is suitable for WB. It exhibits reactivity with Human samples.

Product Specifications

Product Name Alternative

VEGF165; Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; Vegf; VEGFA; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGF A Precursor.

Reactivity

Human

Immunogen

Recombinant human VEGF165 protein (C-His) (27-191/191aa)

Target

VEGFA

Clonality

Polyclonal

Conjugation

IRDye800

Field of Research

Cardiovascular Research

Purification

Affinity purified by Protein A

Dilution

WB=1000-10000

Storage Conditions

Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

0.01M PBS (pH7.4) .

Isotype

IgG

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

3-Bromo-8-chloroimidazo[1,2-a]pyrazine
abx183369-01 1 g

3-Bromo-8-chloroimidazo[1,2-a]pyrazine

Sign In for Pricing
View Details
3-Bromo-8-chloroimidazo[1,2-a]pyrazine
abx183369-02 5 g

3-Bromo-8-chloroimidazo[1,2-a]pyrazine

Sign In for Pricing
View Details
3-Bromo-8-chloroimidazo[1,2-a]pyrazine
abx183369-03 10 g

3-Bromo-8-chloroimidazo[1,2-a]pyrazine

Sign In for Pricing
View Details
TRNAE18 CRISPR Knock Out 293T Cell Line (Human)
47984141 1x 10^6 Cells / 1.0 mL

TRNAE18 CRISPR Knock Out 293T Cell Line (Human)

Sign In for Pricing
View Details
SCP-3 CRISPR/Cas9 KO Plasmid (h)
sc-418308 20 µg

SCP-3 CRISPR/Cas9 KO Plasmid (h)

Sign In for Pricing
View Details
Mouse Or2k2 Pre-designed siRNA Set B
SI109870B 1 Each

Mouse Or2k2 Pre-designed siRNA Set B

Sign In for Pricing
View Details